CORRECTION article

Front. Neurosci., 31 March 2023

Sec. Developmental and Regenerative Neuroscience

Volume 17 - 2023 | https://doi.org/10.3389/fnins.2023.1189154

Corrigendum: Prader-Willi syndrome: Symptoms and topiramate response in light of genetics

  • CL

    Cécile Louveau 1*

  • MT

    Mimi-Caterina Turtulici 1

  • AC

    Angèle Consoli 2,3

  • CP

    Christine Poitou 4

  • MC

    Muriel Coupaye 4

  • MK

    Marie-Odile Krebs 1,5

  • BC

    Boris Chaumette 1,5,6

  • AI

    Anton Iftimovici 1,5*

  • 1. Centre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France

  • 2. Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France

  • 3. GRC-15, Dimensional Approach of Child and Adolescent Psychotic Episodes, Faculté de Médecine, Sorbonne Université, Paris, France

  • 4. Nutrition Department, Rare Diseases Center of Reference “Prader–Willi Syndrome and Obesity With Eating Disorders” (PRADORT), Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, INSERM, Nutriomics, Sorbonne Université, Paris, France

  • 5. Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France

  • 6. Department of Psychiatry, McGill University, Montréal, QC, Canada

In the published article, an author name was incorrectly written as Turtuluci. The correct spelling is Turtulici.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Prader–Willi, topiramate, treatment, genetics, deletion, disomy, personalized medicine

Citation

Louveau C, Turtulici M-C, Consoli A, Poitou C, Coupaye M, Krebs M-O, Chaumette B and Iftimovici A (2023) Corrigendum: Prader-Willi syndrome: Symptoms and topiramate response in light of genetics. Front. Neurosci. 17:1189154. doi: 10.3389/fnins.2023.1189154

Received

18 March 2023

Accepted

20 March 2023

Published

31 March 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

17 - 2023

Updates

Copyright

*Correspondence: Cécile Louveau Anton Iftimovici

This article was submitted to Neurodevelopment, a section of the journal Frontiers in Neuroscience

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics